Mona-Elisabeth R. Revheim
- Group leader, Professor; MD, PhD
- +47 23 07 08 40
UiO email: m.e.rootwelt-revheim@medisin.uio.no
Publications 2024
Elective direct current cardioversion of atrial fibrillation - silent brain infarction and health related quality of life
Cardiology (in press)
DOI 10.1159/000540007, PubMed 39025051
Exploring protocol development: Implementing systematic contextual memory to enhance real-time fMRI neurofeedback
J Electr Bioimpedance, 15 (1), 41-62
DOI 10.2478/joeb-2024-0006, PubMed 38827812
PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking
PET Clin, 19 (4), 569-576
DOI 10.1016/j.cpet.2024.06.002, PubMed 38987123
Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit
Ageing Res Rev, 99, 102348
DOI 10.1016/j.arr.2024.102348, PubMed 38830549
Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
Int J Mol Sci, 25 (7)
DOI 10.3390/ijms25073892, PubMed 38612701
Central nervous system manifestations following vaccination against COVID-19
Brain Behav Immun Health, 38, 100788
DOI 10.1016/j.bbih.2024.100788, PubMed 38818372
FDG-PET in the diagnosis of primary progressive aphasia: a systematic review
Ann Nucl Med, 38 (9), 673-687
DOI 10.1007/s12149-024-01958-w, PubMed 39028529
Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: a review
Ann Nucl Med, 38 (3), 165-175
DOI 10.1007/s12149-023-01896-z, PubMed 38277115
[18F]FDG PET/CT for identifying the causes of fever of unknown origin (FUO)
Am J Nucl Med Mol Imaging, 14 (2), 87-96
DOI 10.62347/OQQC6007, PubMed 38737639
The utility of PET imaging in depression
Front Psychiatry, 15, 1322118
DOI 10.3389/fpsyt.2024.1322118, PubMed 38711875
Comprehensive considerations for dermatologists: the application of FDG-PET in evaluating cutaneous lesions in pediatric Langerhans cell histiocytosis
Front Med (Lausanne), 11, 1378638
DOI 10.3389/fmed.2024.1378638, PubMed 39071084
Positron Emission Tomography (PET) in presurgical planning of anterior temporal lobectomy: A systematic review of efficacy and limitations
Clin Neurol Neurosurg, 246, 108562 (in press)
DOI 10.1016/j.clineuro.2024.108562, PubMed 39326280
Publications 2023
Bacterial Brain Abscesses Expand Despite Effective Antibiotic Treatment: A Process Powered by Osmosis Due to Neutrophil Cell Death
Neurosurgery, 94 (5), 1079-87 (in press)
DOI 10.1227/neu.0000000000002792, PubMed 38084989
Comparative assessment of radiation therapy-induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy
Eur J Nucl Med Mol Imaging, 51 (5), 1444-1450
DOI 10.1007/s00259-023-06535-3, PubMed 38095673
The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19
Eur Phys J Plus, 138 (3), 283
DOI 10.1140/epjp/s13360-023-03797-6, PubMed 37008755
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
Neurological and Psychiatric Manifestations of Long COVID-19 and Their [18F]FDG PET Findings: A Review
Diagnostics (Basel), 13 (14)
DOI 10.3390/diagnostics13142353, PubMed 37510097
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village
Ageing Res Rev, 93, 102173
DOI 10.1016/j.arr.2023.102173, PubMed 38104639
Re: Aducanumab-Related ARIA: Paean or Lament?
Clin Nucl Med, 48 (6), 505-506
DOI 10.1097/RLU.0000000000004509, PubMed 36724162
NaF-PET Imaging of Atherosclerosis Burden
J Imaging, 9 (2)
DOI 10.3390/jimaging9020031, PubMed 36826950
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease
Clin Nucl Med, 48 (8), 689-691
DOI 10.1097/RLU.0000000000004710, PubMed 37314733
Passive Alzheimer's immunotherapy: A promising or uncertain option?
Ageing Res Rev, 90, 101996
DOI 10.1016/j.arr.2023.101996, PubMed 37414156
FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls
Diagnostics (Basel), 13 (13)
DOI 10.3390/diagnostics13132254, PubMed 37443645
Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival
Comput Methods Programs Biomed, 244, 107934
DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391
Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936
First experience with 224Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230
Optimization of Q.Clear reconstruction for dynamic 18F PET imaging
EJNMMI Phys, 10 (1), 65
DOI 10.1186/s40658-023-00584-1, PubMed 37861929
A prospective 18 F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection
AIDS, 37 (6), 905-912
DOI 10.1097/QAD.0000000000003485, PubMed 36727840
The role of 18F-FDG PET/CT in primary cutaneous lymphoma: an educational review
Ann Nucl Med, 37 (6), 328-348
DOI 10.1007/s12149-023-01830-3, PubMed 37095393
Utility of a simplified [18F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
Front Endocrinol (Lausanne), 14, 1236881
DOI 10.3389/fendo.2023.1236881, PubMed 37780613
18F-FDG and 18F-NaF PET/CT Global Assessment of Large Joint Inflammation and Bone Turnover in Rheumatoid Arthritis
Diagnostics (Basel), 13 (13)
DOI 10.3390/diagnostics13132149, PubMed 37443544
Is Imaging Bacteria with PET a Realistic Option or an Illusion?
Diagnostics (Basel), 13 (7)
DOI 10.3390/diagnostics13071231, PubMed 37046449
Advancements in dendritic cell vaccination: enhancing efficacy and optimizing combinatorial strategies for the treatment of glioblastoma
Front Neurol, 14, 1271822
DOI 10.3389/fneur.2023.1271822, PubMed 38020665
Aging and Cerebral Glucose Metabolism: 18F-FDG-PET/CT Reveals Distinct Global and Regional Metabolic Changes in Healthy Patients
Life (Basel), 13 (10)
DOI 10.3390/life13102044, PubMed 37895426
The Role of FDG-PET in the Evaluation of Hidradenitis Suppurativa: A Systematic Review
J Clin Med, 12 (17)
DOI 10.3390/jcm12175491, PubMed 37685556
Publications 2022
Potential and Most Relevant Applications of Total Body PET/CT Imaging
Clin Nucl Med, 47 (1), 43-55
DOI 10.1097/RLU.0000000000003962, PubMed 34874348
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not
Clin Nucl Med, 47 (6), 532-536
DOI 10.1097/RLU.0000000000004131, PubMed 35384906
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
PET Clin, 17 (3), 431-451
DOI 10.1016/j.cpet.2022.03.002, PubMed 35662494
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors
Diagnostics (Basel), 12 (2)
DOI 10.3390/diagnostics12020528, PubMed 35204618
Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
Int J Mol Sci, 23 (18)
DOI 10.3390/ijms231810268, PubMed 36142181
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects-Atherosclerosis for a Start
J Alzheimers Dis, 88 (2), 455-458
DOI 10.3233/JAD-220190, PubMed 35599491
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
J Alzheimers Dis, 90 (4), 1395-1399
DOI 10.3233/JAD-220841, PubMed 36278356
Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?
Clin Nucl Med, 47 (7), 625-626
DOI 10.1097/RLU.0000000000004250, PubMed 35452007
Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography
PET Clin, 17 (4), 631-640
DOI 10.1016/j.cpet.2022.07.007, PubMed 36229105
Volumetric parameters from [18 F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 34 (7), e13170
DOI 10.1111/jne.13170, PubMed 35729738
FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol, 24 (5), 807-817
DOI 10.1007/s11307-022-01731-3, PubMed 35486292
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
Front Oncol, 12, 1031232
DOI 10.3389/fonc.2022.1031232, PubMed 36439452
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
J Alzheimers Dis, 85 (1), 197-205
DOI 10.3233/JAD-215046, PubMed 34776444
Evaluation of semi-quantitative measures of 18F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096
Application of 18F-NaF-PET/CT in assessing age-related changes in the cervical spine
Quant Imaging Med Surg, 12 (6), 3314-3324
DOI 10.21037/qims-21-1174, PubMed 35655822
Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using 18F-Sodium Fluoride PET/Computed Tomography
PET Clin, 17 (4), 653-659
DOI 10.1016/j.cpet.2022.07.009, PubMed 36229106
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand 212Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766
Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
Mol Imaging Biol, 24 (5), 842-851
DOI 10.1007/s11307-022-01734-0, PubMed 35501622
Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
Front Med (Lausanne), 9, 1058863
DOI 10.3389/fmed.2022.1058863, PubMed 36507500
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma
Nucl Med Commun, 43 (7), 800-806
DOI 10.1097/MNM.0000000000001573, PubMed 35552334
Publications 2021
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting
Am J Nucl Med Mol Imaging, 11 (5), 337-351
PubMed 34754605
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT
J Nucl Cardiol, 28 (6), 3044-3054
DOI 10.1007/s12350-020-02446-0, PubMed 33389640
Tau Imaging in Head Injury
PET Clin, 16 (2), 249-260
DOI 10.1016/j.cpet.2020.12.009, PubMed 33648666
Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck
Nucl Med Commun, 42 (4), 416-420
DOI 10.1097/MNM.0000000000001344, PubMed 33306627
A Critical Review of PET Tracers Used for Brain Tumor Imaging
PET Clin, 16 (2), 219-231
DOI 10.1016/j.cpet.2020.12.004, PubMed 33589386
Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk
Nucl Med Commun, 42 (4), 444-450
DOI 10.1097/MNM.0000000000001349, PubMed 33323870
Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and 18F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
Front Immunol, 11, 617985
DOI 10.3389/fimmu.2020.617985, PubMed 33584710
Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature
PET Clin, 16 (2), 273-284
DOI 10.1016/j.cpet.2020.12.005, PubMed 33589388
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
PET Clin, 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Am J Nucl Med Mol Imaging, 11 (5), 387-394
PubMed 34754609
Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial
Am J Nucl Med Mol Imaging, 11 (5), 415-427
PubMed 34754612
Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation
Am J Nucl Med Mol Imaging, 11 (2), 99-106
PubMed 34079639
Emerging role of 18F-FDG PET/CT in Castleman disease: a review
Insights Imaging, 12 (1), 35
DOI 10.1186/s13244-021-00963-1, PubMed 33709329
18F-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am J Nucl Med Mol Imaging, 11 (1), 1-9
PubMed 33688450
F-18-FDG-PET/CT in the assessment of atherosclerosis in lung cancer
Am. J. Nucl. Med. Molec. Imaging, 11 (1), 1-+
A comparative analysis: international variation in PET-CT service provision in oncology-an International Cancer Benchmarking Partnership study
Int J Qual Health Care, 33 (1)
DOI 10.1093/intqhc/mzaa166, PubMed 33306102
Novel Musculoskeletal and Orthopedic Applications of 18F-Sodium Fluoride PET
PET Clin, 16 (2), 295-311
DOI 10.1016/j.cpet.2020.12.006, PubMed 33589389
PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders
Diagnostics (Basel), 11 (12)
DOI 10.3390/diagnostics11122234, PubMed 34943473
PET-based Novel Imaging Techniques with Recently Introduced Radiotracers. Preface
PET Clin, 16 (2), xv-xvi
DOI 10.1016/j.cpet.2021.01.001, PubMed 33648667
Multimodal functional imaging for early response assessment in patients with gastrointestinal stromal tumor treated with tyrosine kinase inhibitors
Acta Radiol, 63 (8), 995-1004
DOI 10.1177/02841851211027389, PubMed 34171968
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Clin. Transl. Imaging
DOI 10.1007/s40336-021-00466-5
18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
PET Clin, 16 (2), 167-176
DOI 10.1016/j.cpet.2020.12.012, PubMed 33648662
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancer
Am J Nucl Med Mol Imaging, 11 (4), 250-259
PubMed 34513278
Publications 2020
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy
Eur J Nucl Med Mol Imaging, 48 (2), 623-641
DOI 10.1007/s00259-020-04926-4, PubMed 32696090
18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am J Nucl Med Mol Imaging, 10 (1), 66-73
PubMed 32211220
F-18-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis
Am. J. Nucl. Med. Molec. Imaging, 10 (1), 66-73
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
Eur J Nucl Med Mol Imaging, 47 (11), 2493-2498
DOI 10.1007/s00259-020-04697-y, PubMed 31982989
Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammation
JRSM Cardiovasc Dis, 9, 2048004020980941
DOI 10.1177/2048004020980941, PubMed 33403110
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system
Am J Nucl Med Mol Imaging, 10 (5), 265-271
PubMed 33224623
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology
Nucl Med Commun, 41 (2), 162-168
DOI 10.1097/MNM.0000000000001127, PubMed 31860525
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
Eur J Nucl Med Mol Imaging, 48 (6), 1902-1914
DOI 10.1007/s00259-020-05098-x, PubMed 33196921
Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder
Front Physiol, 11, 511391
DOI 10.3389/fphys.2020.511391, PubMed 33192540
18F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation
Eur J Hybrid Imaging, 4 (1), 22
DOI 10.1186/s41824-020-00091-x, PubMed 34191165
Quantitative thoracic aorta calcification assessment by 18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age
Eur Radiol, 31 (2), 785-794
DOI 10.1007/s00330-020-07133-9, PubMed 32870396
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
Nucl Med Commun, 41 (3), 288-293
DOI 10.1097/MNM.0000000000001144, PubMed 31895757
β-Amyloid may accumulate in the human brain after focal bacterial infection: An 18 F-flutemetamol positron emission tomography study
Eur J Neurol, 28 (3), 877-883
DOI 10.1111/ene.14622, PubMed 33131195
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients
Ann Nucl Med, 34 (6), 424-431
DOI 10.1007/s12149-020-01463-w, PubMed 32277422
Correlation of whole-bone marrow dual-time-point F-18-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am. J. Nucl. Med. Molec. Imaging, 10 (5), 257-264
Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (4), 151-160
PubMed 32929393
Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects
Am J Nucl Med Mol Imaging, 10 (2), 119-126
PubMed 32419980
Diagnosis and Monitoring of Osteoporosis with Total-Body 18F-Sodium Fluoride-PET/CT
PET Clin, 15 (4), 487-496
DOI 10.1016/j.cpet.2020.06.011, PubMed 32768370
Correlation of whole-bone marrow dual-time-point 18F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients
Am J Nucl Med Mol Imaging, 10 (5), 257-264
PubMed 33224622
Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy
Eur J Nucl Med Mol Imaging, 47 (12), 2846-2855
DOI 10.1007/s00259-020-04768-0, PubMed 32246208
Publications 2019
Assessing respitatory muscle activity with 18F-FDG-PET/CT in patients with COPD
Am J Nucl Med Mol Imaging, 9 (6), 309-315
PubMed 31976160
64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
Oncol Ther, 8 (1), 125-131
DOI 10.1007/s40487-019-00104-1, PubMed 32700066
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334
Publications 2018
Dynamic TSPO-PET for assessing early effects of cerebral hypoxia and resuscitation in new born pigs
Nucl Med Biol, 66, 49-57
DOI 10.1016/j.nucmedbio.2018.08.004, PubMed 30257223
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation
Nucl Med Commun, 39 (7), 621-627
DOI 10.1097/MNM.0000000000000843, PubMed 29683930
The Effect of New Formulas for Lean Body Mass on Lean-Body-Mass-Normalized SUV in Oncologic 18F-FDG PET/CT
J Nucl Med Technol, 46 (3), 253-259
DOI 10.2967/jnmt.117.204586, PubMed 29599401
[Not Available]
Tidsskr Nor Laegeforen, 138 (15)
DOI 10.4045/tidsskr.18.0200, PubMed 30277049
Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
Acta Radiol, 60 (8), 1028-1038
DOI 10.1177/0284185118810977, PubMed 30379559
Comparison of time curves from dynamic 18F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
Phys Imaging Radiat Oncol, 7, 51-57
DOI 10.1016/j.phro.2018.09.003, PubMed 33458405
Publications 2017
Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue dose
Acta Radiol, 59 (2), 132-139
DOI 10.1177/0284185117710052, PubMed 28509566
The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Eur J Nucl Med Mol Imaging, 45 (2), 218-225
DOI 10.1007/s00259-017-3843-9, PubMed 29026950
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases
Br J Surg, 105 (3), 295-301
DOI 10.1002/bjs.10651, PubMed 29168565
18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques
J Nucl Cardiol, 26 (3), 883-893
DOI 10.1007/s12350-017-1121-7, PubMed 29209949
Publications 2015
Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case report
J Med Case Rep, 9, 281
DOI 10.1186/s13256-015-0749-7, PubMed 26654961
Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients
Int J Stroke, 10 (5), 730-6
DOI 10.1111/ijs.12430, PubMed 25588553
Publications 2014
Respiratory gated and prolonged acquisition 18F-FDG PET improve preoperative assessment of colorectal liver metastases
Acta Radiol, 56 (4), 397-403
DOI 10.1177/0284185114529563, PubMed 24682406
Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin
BMJ Case Rep, 2014
DOI 10.1136/bcr-2014-206225, PubMed 25391823
Publications 2013
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338
Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
Nucl Med Mol Imaging, 47 (3), 173-80
DOI 10.1007/s13139-013-0211-y, PubMed 24900104
Dynamic (18)F-FDG-PET for monitoring treatment effect following anti-angiogenic therapy in triple-negative breast cancer xenografts
Acta Oncol, 52 (7), 1566-72
DOI 10.3109/0284186X.2013.813634, PubMed 23984812
Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
Acta Oncol, 53 (1), 143-8
DOI 10.3109/0284186X.2013.798428, PubMed 23710697
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
Acta Oncol, 52 (4), 776-82
DOI 10.3109/0284186X.2013.770920, PubMed 23480638
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holds
Acta Radiol, 54 (6), 672-5
DOI 10.1177/0284185113478007, PubMed 23463858
Publications 2012
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812
Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas
Acta Oncol, 52 (6), 1160-7
DOI 10.3109/0284186X.2012.728713, PubMed 23198721
Publications 2011
Monitoring the effect of targeted therapies in a gastrointestinal stromal tumor xenograft using a clinical PET/CT
Mol Imaging Biol, 13 (6), 1234-40
DOI 10.1007/s11307-010-0464-0, PubMed 21161686
Publications 2010
DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour
Acta Oncol, 50 (1), 148-50
DOI 10.3109/0284186X.2010.516273, PubMed 21110775
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733
Publications 2009
Establishment and characterization of a human gastrointestinal stromal tumour (GIST) xenograft in athymic nude mice
Anticancer Res, 29 (11), 4331-6
PubMed 20032375